Glyscend Incorporated

0 followers

‌

Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes.

Industries

Biotechnology

Headquarters

Baltimore, United States

Employees

11-50

Links

Org chart

Sapan Shah

CEO

Sapan Shah

Collapse

Ashish Nimgaonkar

Chief Medical Officer & Head, R&D

Mark Fineman

Chief Development Officer

Bob Soh

Director

Christine Bryant

Senior Director Clinical & Translational Science

Teams

Advisory Team

10 members

Research and Development Team

3 members

Leadership Team

3 members

Offices

Similar companies

Agilent Technologies

69 followers

Neuralink

62 followers

BioMarin Pharmaceutical

36 followers

GRAIL

27 followers

Avantor

10 followers

Cepheid

7 followers

Spectrix Analytical Services

1 follower

Editas Medicine

4 followers

Arcus Biosciences

3 followers

Merck

228 followers

Iovance Biotherapeutics

3 followers

Explore companies

��������